To cite this paper use one of the standards below:
Zika virus (ZIKV) infection is associated with severe neurological complications, including Guillain-Barré syndrome in adults and microcephaly in infants born from infected mothers. ¹ Although its significant public health impact, no specific antiviral therapy is currently available for ZIKV infection. In previous studies, our research group identified urea derivatives with inhibitory activity against the viral NS3 helicase, an essential enzyme required for viral replication.² Based on these promising results, we are synthesizing enantiomerically pure phenyl ureas to investigate the influence of stereochemistry on their antiviral activity. Therefore, (S)-1-(2-hydroxypropyl)-3-phenylurea (1a) was successfully obtained in 95% yield via the in situ generation of phenyl isocyanate from aniline and triphosgene, followed by reaction with (S)-1-aminopropan-2-ol.3 We are now performing the synthesis of the enantiomeric enriched compounds 2 and 3, as well as new analogs from substituted anilines towards the development of potential Zika virus NS3 hel inhibitors
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper